Skip to main content
. 2015 Apr 24;5:9773. doi: 10.1038/srep09773

Figure 3. Inhibition of HCV replication.

Figure 3

(a) Effect of T-plastin knock-down measured by Renilla luciferase activity. (b) Two target sites of T-plastin RNAi. (c) Dose-dependent HCV replication inhibition effect of prolonged Flu-IA treatments. (d) Cell viability test by an MTT assay in response to serial concentrations of Flu-IA treatment. All mean and standard deviation data were obtained from quadruplicate experiments (N = 4).